June 2011

Boston Scientific launches Interlock

Thursday, June 30, 2011

Boston Scientific has launched its Interlock-35 Fibered IDC Occlusion System in the U.S. and Europe.  Earlier this year, the system received clearance from the FDA and CE Mark approval for obstructing or reducing blood flow in the peripheral vasculature during embolization procedures.

[Read More]

Sorbent expands financing by $36 million

Thursday, June 30, 2011

Sorbent Therapeutics, a biopharmaceutical company, has expanded its Series B financing from September 2010 by $36 million. This brings the total proceeds of the second financing round to $53 million. Investor Novartis Venture Funds led the financing, joining existing investors Sofinnova Ventures, ARCH Venture Partners, CMEA Capital and AgeChem.

[Read More]